key: cord-0975740-1qybn2i9
authors: Suh, Minseok
title: In the COVID-19 Era, Is It OK to Perform a Perfusion-Only SPECT/CT for the Diagnosis of Pulmonary Embolism?
date: 2022-03-03
journal: Nucl Med Mol Imaging
DOI: 10.1007/s13139-022-00740-y
sha: 41dc827fb47de56ce75b73ac18bca20667a9d672
doc_id: 975740
cord_uid: 1qybn2i9

nan

51% to as high as 94%. The study by Le Roux et al., which included the largest number of 393 patients, reported a specificity of 85% and a corresponding false-positive rate of 15%. Overall, perfusion-only SPECT/CT showed a relatively high false-positive rate of around 20%, so there is a possibility of overdiagnosis. The reason for the relatively high false-positive rate has not yet been well elucidated. Palmowski et al. hypothesized that vasoconstriction due to hypoxia can cause mild functional ventilatory disturbances present in ventilation SPECT but are morphologically invisible on low-dose CT [9] .

The article published in this issue, "Utility of lung perfusion SPECT/CT in the detection of pulmonary thromboembolic disease: outcome analysis," also reports consistent results in pulmonary thromboembolic disease, including both pulmonary embolism and chronic thromboembolic pulmonary hypertension patients [12] . Based on a composite reference standard including clinical presentation, laboratory test results, other imaging test results, and follow-up data, it showed a sensitivity of 100% and a specificity of 78.6%. In line with the previous studies, the false-positive rate was relatively high at 21.4%.

Furthermore, a recent multicenter trial evaluated the role of lung scintigraphy in 145 COVID-19 patients, suspected of pulmonary embolism [13] . Compared with perfusion-only SPECT/CT, when ventilation/perfusion SPECT/CT was performed, an additional 31% of patients were able to rule out pulmonary embolism. Indeed, in the Spanish cohort, the standardized incidence of pulmonary embolism in the COVID-19 population was 310 cases per 100,000 person-years, which is significantly higher than that observed in the non-COVID-19 population (35 cases per 100,000 person-years) [14] . In hospitalized patients with COVID-19, the incidence of pulmonary embolism is reported to be as high as approximately 2.6-8.9% [15] . Given the high incidence of pulmonary embolism in the COVID-19 population, the high false-positive rate of perfusion-only SPECT/CT has important implications.

Comprehensively, omitting ventilation scans will eventually lead to overdiagnosis of pulmonary thromboembolic NPV, negative predictive value disease. Anticoagulation is the mainstay of treatment after the diagnosis of pulmonary embolism. Risks with continued use of anticoagulant therapy include bleeding, interactions with other drugs, repeated blood tests, and increased overall cost [16] . Diagnosis of pulmonary embolism also affects life insurance and medical procedures including preparation for surgery. Furthermore, it may lead to preoccupation with the patient, which can influence medical attention for similar symptoms in the future. In this context, the risk-benefit of performing perfusion-only SPECT/CT should be considered in the COVID-19 era.

There is no unified guideline for lung scintigraphy procedures to diagnose pulmonary embolism, and various strategies are recommended according to the circumstance of each medical facility, region, and country [17] . In line with Le Roux et al. [18] , considering the risk-benefit of perfusion-only SPECT/CT omitting the ventilation scan cannot be justified, even in the COVID-19 situation. However, given the high sensitivity of perfusion-only SPECT/CT, it can be used in the pre-screening of patients, who are to be helped by ventilation scan. When ventilation scan is additionally performed only on subjects who have positive findings in perfusion-only SPECT/CT, both the transmission of COVID-19 and the risk of overdiagnosis can be minimized. Zuckier et al. have proposed a similar strategy to use stand-alone perfusion scintigraphy as a screening tool [19] .

After the screening of eligible patients, preparations for protection must be made from the perspective of the patient, health care workers, and the environment. Patients should be pre-screened for symptoms with a questionnaire on arrival and checking body temperature, to verify if they are likely to have a COVID-19 infection. For the pulmonary function test (PFT), some countries recommend that the documented negative swab test result be presented 48-72 h prior to the test [20] ; this can also be considered before the ventilation scan according to the circumstances. There are guidance documents for the protection of health care workers in the nuclear medicine procedure from COVID-19 infection [21] [22] [23] . Guidelines for PFT can also be referred to [20] . The guidelines commonly recommend wearing an appropriate filtering facepiece, and since there may be direct contact with respiratory droplets derived during the test, wearing a glove, visor, and gown is also recommended. In-between the procedure, the operator is recommended to stand next to the patient, facing the same direction, and to avoid face-to-face. Finally, after the examination, proper equipment cleaning and room ventilation are required. If more than one scan is to be performed in a row, timely reservations should be made to allow sufficient recirculation of the room [20, 22] .

In the era of the COVID-19 pandemic (global pandemic), ventilation scan is recognized as a procedure that requires caution due to the potential for secretion of respiratory droplets containing viruses. It has been suggested that ventilation can be replaced by perfusion-only SPECT combined with CT giving information on structural abnormality. However, from a comprehensive perspective, perfusion-only SPECT/CT has the potential to increase the risk of overdiagnosis in pulmonary thromboembolic disease patients. Therefore, rather than replacing the ventilation scan with perfusion-only SPECT/CT, it should be used as a tool to pre-screen patients and if a ventilation scan is required, it is recommended to perform the procedure with appropriate preparation for protection.

Is there a role for lung perfusion [(99m)Tc]-MAA SPECT/CT to rule out pulmonary embolism in COVID-19 patients with contraindications for iodine contrast?

Perfusion SPECT/CT to diagnose pulmonary embolism during COVID-19 pandemic

The American College of Nuclear Medicine Guidance on operating procedures for a nuclear medicine facility during COVID-19 pandemic

Comparison of two different segmentation methods on planar lung perfusion scan with reference to quantitative value on SPECT/CT

Detection of pulmonary embolism with combined ventilation-perfusion SPECT and low-dose CT: head-to-head comparison with multidetector CT angiography

Additional value of combining low-dose computed tomography to V/Q SPECT on a hybrid SPECT-CT camera for pulmonary embolism diagnosis

Noncontrast perfusion single-photon emission CT/CT scanning: a new test for the expedited, high-accuracy diagnosis of acute pulmonary embolism

The utility of hybrid SPECT/CT lung perfusion scintigraphy in pulmonary embolism diagnosis

Diagnosis of pulmonary embolism: conventional ventilation/perfusion SPECT is superior to the combination of perfusion SPECT and nonenhanced CT

Diagnosis of pulmonary embolism: a comparison between ventilation/perfusion SPECT/CT and perfusion-only SPECT/CT

A prospective, comparative study of ventilation-perfusion planar imaging and ventilation-perfusion SPECT for chronic thromboembolic pulmonary hypertension

Utility of lung perfusion SPECT/CT in detection of pulmonary thromboembolic disease: outcome analysis

Lung scintigraphy for pulmonary embolism diagnosis in COVID-19 patients: a multicenter study

Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome

Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review

Overdiagnosis of pulmonary embolism by pulmonary CT angiography

To everything there is a season: taxonomy of approaches to the performance of lung scintigraphy in the era of COVID-19

Lung scintigraphy for pulmonary embolism diagnosis during the COVID-19 pandemic: does the benefit-risk ratio really justify omitting the ventilation study?

Diagnostic evaluation of pulmonary embolism during the COVID-19 pandemic

Practical considerations for spirometry during the COVID-19 outbreak: literature review and insights

COVID-19 and ventilation/perfusion (V/Q) lung studies

COVID-19: guidance for infection prevention and control in nuclear medicine

KSNM/KSID/KOSHIC guidance for nuclear medicine department against the coronavirus disease 2019 (COVID-19) pandemic

Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations